Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 4,286 | 3,269 | 11,688 | 1,750 | 0 |
| Cost of Goods | 534 | 371 | 216 | 271 | N/A |
| Gross Profit | 3,752 | 2,898 | 11,472 | 1,479 | 135 |
| Operating Expenses | 26,275 | 26,760 | 178,865 | 41,639 | 21,931 |
| Operating Income | -21,989 | -23,491 | -167,177 | -39,889 | -21,931 |
| Interest Expense | 1,161 | 1,092 | 1,070 | 1,067 | 444 |
| Other Income | -31 | -130 | 548 | 723 | 877 |
| Pre-tax Income | -23,181 | -24,713 | -167,699 | -40,233 | -21,498 |
| Income Tax | 0 | 1 | -259 | 0 | 0 |
| Net Income Continuous | -23,181 | -24,714 | -167,440 | -40,233 | -21,498 |
| Net Income | $-23,181 | $-24,714 | $-167,440 | $-40,233 | $-21,498 |
| EPS Basic Total Ops | 23.92 | -10.61 | -86.87 | -68.17 | -64.03 |
| EPS Basic Continuous Ops | 23.78 | -10.60 | -86.88 | -68.09 | -64.31 |
| EPS Diluted Total Ops | 23.92 | -10.61 | -86.87 | -68.17 | -64.03 |
| EPS Diluted Continuous Ops | 23.78 | -10.60 | -86.88 | -68.09 | -64.31 |
| EBITDA(a) | $-21,902 | $-23,424 | $-112,738 | $-39,796 | $-21,837 |